会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Device for measuring the density of a fluid
    • 用于测量流体密度的装置
    • US4177669A
    • 1979-12-11
    • US925751
    • 1978-07-18
    • Alfred Wenger
    • Alfred Wenger
    • G01N9/00
    • G01N9/002
    • The device includes an oscillation body and an electronic circuitry component connected to an oscillation detector and to plural oscillation generators, and including a period of frequency meter, phase shifters supplying the generators with an excitation signal shifted in phase relative to the detector signal, and a modulator. The phase angle between the detector and excitation signals, and the oscillating frequency, are varied substantially periodically within a given interval at a frequency which is lower than the oscillation frequency. Control elements control the phase and frequency position of the interval as a function of the variation of the ratio of the detector signal to the excitation signal, and of the relation between the variations, within the interval, of the detector and excitation signals and the phase angle therebetween.
    • 该装置包括振荡体和连接到振荡检测器和多个振荡发生器的电子电路部件,并且包括频率计周期,移相器向发生器提供相对于检测器信号相移的激励信号,以及 调制器。 检测器和激励信号之间的相位角以及振荡频率在给定的间隔内基本周期地以低于振荡频率的频率变化。 控制元件控制间隔的相位和频率位置作为检测器信号与激励信号的比率变化的函数,以及在检测器和激励信号的间隔内的变化与相位之间的关系的函数 之间的角度。
    • 10. 发明申请
    • ENAMEL MATRIX PROTEIN COMPOSITION FOR TREATMENT OF SYSTEMIC INFLAMMATORY RESPONSE
    • 用于治疗系统性炎症反应的ENAMEL MATRIX蛋白组合物
    • US20100093632A1
    • 2010-04-15
    • US12575086
    • 2009-10-07
    • Stina GestreliusPetter Lyngstadaas
    • Stina GestreliusPetter Lyngstadaas
    • A61K38/17
    • A61K35/32A61K38/39Y02A50/473
    • The present invention relates to the use of a preparation of an active enamel matrix substance, such as an amelogenin, for the manufacture of a pharmaceutical composition for modulating an immune response. The composition can be used in preventing and/or treating a condition or disease in a mammal that is characterised by said mammal presenting an imbalance in its native immune response to an internal and/or external stimuli, i.e. wherein at least a part of said mammal's immune system is stimulated non-discriminatingly, reacts hypersensitively to said immunogen, or fails to react to said stimuli. Said condition can typically either be systemic or local, such as a systemic and/or post-traumatic whole-body inflammation or an autoimmune disease.
    • 本发明涉及用于制备用于调节免疫应答的药物组合物的活性釉质基质物质例如青蒿素的制备的用途。 所述组合物可用于预防和/或治疗哺乳动物的病症或疾病,所述哺乳动物的特征在于所述哺乳动物对其内部和/或外部刺激的天然免疫反应呈现不平衡,即其中所述哺乳动物的至少一部分 免疫系统被无歧视地刺激,对所述免疫原过敏反应或者不能对所述刺激物反应。 所述病症通常可以是全身性的或局部的,例如全身和/或创伤后全身炎症或自身免疫性疾病。